Bridger Gary
Insider CIK 1600049 · AQXP Director · ALDR Director · XFOR Director · XENE EVP, Research & Development
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| XFOR X4 Pharmaceuticals, Inc | A Award deriv | 2026-01-01 | 2026-01-07 | 110,000 | — | $0 | 0 | SEC↗ |
| XFOR X4 Pharmaceuticals, Inc | A Award | 2025-06-09 | 2025-06-10 | 1,500 | — | $0 | 4,722 | SEC↗ |
| XFOR X4 Pharmaceuticals, Inc | A Award | 2024-06-10 | 2024-06-11 | 45,000 | — | $0 | 96,667 | SEC↗ |
| XFOR X4 Pharmaceuticals, Inc | A Award | 2023-06-13 | 2023-06-14 | 45,000 | — | $0 | 51,667 | SEC↗ |
| XFOR X4 Pharmaceuticals, Inc | A Award | 2022-06-06 | 2022-06-27 | 6,667 | — | $0 | 6,667 | SEC↗ |
| XFOR X4 Pharmaceuticals, Inc | A Award deriv | 2021-06-02 | 2021-06-02 | 6,000 | $9.50 | $57.0K | 6,000 | SEC↗ |
| XFOR X4 Pharmaceuticals, Inc | A Award deriv | 2020-10-05 | 2020-10-06 | 30,000 | — | $0 | 30,000 | SEC↗ |
| XFOR X4 Pharmaceuticals, Inc | A Award deriv | 2020-06-10 | 2020-06-11 | 3,427 | — | $0 | 3,427 | SEC↗ |
| XFOR X4 Pharmaceuticals, Inc | A Award deriv | 2019-03-13 | 2019-04-02 | 6,854 | — | $0 | 6,854 | SEC↗ |
| XFOR X4 Pharmaceuticals, Inc | A Award deriv | 2019-03-13 | 2019-04-02 | 21,570 | — | $0 | 21,570 | SEC↗ |
| XFOR X4 Pharmaceuticals, Inc | A Award deriv | 2019-03-13 | 2019-03-14 | 21,570 | — | $0 | 21,570 | SEC↗ |
| AQXP AQUINOX PHARMACEUTICALS, I | A Award deriv | 2018-05-07 | 2018-05-09 | 15,000 | — | $0 | 15,000 | SEC↗ |
| AQXP AQUINOX PHARMACEUTICALS, I | A Award deriv | 2017-05-08 | 2017-05-10 | 9,000 | — | $0 | 9,000 | SEC↗ |
| AQXP AQUINOX PHARMACEUTICALS, I | A Award deriv | 2016-05-09 | 2016-05-11 | 7,500 | — | $0 | 7,500 | SEC↗ |
| AQXP AQUINOX PHARMACEUTICALS, I | J Other | 2015-10-31 | 2015-11-03 | 1,543,989 | — | $0 | 0 | SEC↗ |
| ALDR ALDER BIOPHARMACEUTICALS I | J Other | 2015-10-31 | 2015-11-03 | 3,469,528 | — | $0 | 0 | SEC↗ |
| ALDR ALDER BIOPHARMACEUTICALS I | A Award deriv | 2015-05-19 | 2015-05-21 | 6,350 | — | $0 | 6,350 | SEC↗ |
| AQXP AQUINOX PHARMACEUTICALS, I | A Award deriv | 2015-03-12 | 2015-03-16 | 5,000 | — | $0 | 5,000 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | A Award deriv | 2014-11-21 | 2014-11-25 | 5,144 | — | $0 | 5,144 | SEC↗ |
| ALDR ALDER BIOPHARMACEUTICALS I | C Conversion deriv | 2014-05-13 | 2014-05-15 | 853,146 | — | $0 | 0 | SEC↗ |
| ALDR ALDER BIOPHARMACEUTICALS I | C Conversion deriv | 2014-05-13 | 2014-05-15 | 1,027,668 | — | $0 | 0 | SEC↗ |
| ALDR ALDER BIOPHARMACEUTICALS I | C Conversion deriv | 2014-05-13 | 2014-05-15 | 841,750 | — | $0 | 0 | SEC↗ |
| ALDR ALDER BIOPHARMACEUTICALS I | C Conversion deriv | 2014-05-13 | 2014-05-15 | 496,964 | — | $0 | 0 | SEC↗ |
| ALDR ALDER BIOPHARMACEUTICALS I | C Conversion | 2014-05-13 | 2014-05-15 | 3,219,528 | — | $0 | 3,219,528 | SEC↗ |
| ALDR ALDER BIOPHARMACEUTICALS I | P Buy | 2014-05-13 | 2014-05-15 | 250,000 | $10.00 | $2.50M | 3,469,528 | SEC↗ |
| AQXP AQUINOX PHARMACEUTICALS, I | C Conversion deriv | 2014-03-12 | 2014-03-14 | 326,538 | — | $0 | 0 | SEC↗ |
| AQXP AQUINOX PHARMACEUTICALS, I | C Conversion deriv | 2014-03-12 | 2014-03-14 | 189,393 | — | $0 | 0 | SEC↗ |
| AQXP AQUINOX PHARMACEUTICALS, I | C Conversion deriv | 2014-03-12 | 2014-03-14 | 189,393 | — | $0 | 0 | SEC↗ |
| AQXP AQUINOX PHARMACEUTICALS, I | C Conversion deriv | 2014-03-12 | 2014-03-14 | 189,393 | — | $0 | 0 | SEC↗ |
| AQXP AQUINOX PHARMACEUTICALS, I | C Conversion deriv | 2014-03-12 | 2014-03-14 | 284,090 | — | $0 | 0 | SEC↗ |
| AQXP AQUINOX PHARMACEUTICALS, I | C Conversion deriv | 2014-03-12 | 2014-03-14 | 284,090 | — | $0 | 0 | SEC↗ |
| AQXP AQUINOX PHARMACEUTICALS, I | C Conversion deriv | 2014-03-12 | 2014-03-14 | 284,090 | — | $0 | 0 | SEC↗ |
| AQXP AQUINOX PHARMACEUTICALS, I | C Conversion deriv | 2014-03-12 | 2014-03-14 | 40,147 | — | $0 | 0 | SEC↗ |
| AQXP AQUINOX PHARMACEUTICALS, I | A Award deriv | 2014-03-12 | 2014-03-14 | 36,502 | $11.00 | $401.5K | 40,147 | SEC↗ |
| AQXP AQUINOX PHARMACEUTICALS, I | C Conversion deriv | 2014-03-12 | 2014-03-14 | 378,786 | — | $0 | 0 | SEC↗ |
| AQXP AQUINOX PHARMACEUTICALS, I | C Conversion deriv | 2014-03-12 | 2014-03-14 | 378,786 | — | $0 | 0 | SEC↗ |
| AQXP AQUINOX PHARMACEUTICALS, I | C Conversion deriv | 2014-03-12 | 2014-03-14 | 378,786 | — | $0 | 0 | SEC↗ |
| AQXP AQUINOX PHARMACEUTICALS, I | C Conversion deriv | 2014-03-12 | 2014-03-14 | 325,035 | — | $0 | 0 | SEC↗ |
| AQXP AQUINOX PHARMACEUTICALS, I | C Conversion deriv | 2014-03-12 | 2014-03-14 | 325,035 | — | $0 | 0 | SEC↗ |
| AQXP AQUINOX PHARMACEUTICALS, I | C Conversion deriv | 2014-03-12 | 2014-03-14 | 325,035 | — | $0 | 0 | SEC↗ |
| AQXP AQUINOX PHARMACEUTICALS, I | C Conversion deriv | 2014-03-12 | 2014-03-14 | 326,538 | — | $0 | 0 | SEC↗ |
| AQXP AQUINOX PHARMACEUTICALS, I | C Conversion deriv | 2014-03-12 | 2014-03-14 | 326,538 | — | $0 | 0 | SEC↗ |
| AQXP AQUINOX PHARMACEUTICALS, I | D To issuer | 2014-03-12 | 2014-03-14 | 189,393 | — | $0 | 0 | SEC↗ |
| AQXP AQUINOX PHARMACEUTICALS, I | D To issuer | 2014-03-12 | 2014-03-14 | 378,786 | — | $0 | 0 | SEC↗ |
| AQXP AQUINOX PHARMACEUTICALS, I | D To issuer | 2014-03-12 | 2014-03-14 | 325,035 | — | $0 | 0 | SEC↗ |
| AQXP AQUINOX PHARMACEUTICALS, I | D To issuer | 2014-03-12 | 2014-03-14 | 326,538 | — | $0 | 0 | SEC↗ |
| AQXP AQUINOX PHARMACEUTICALS, I | C Conversion | 2014-03-12 | 2014-03-14 | 1,543,989 | — | $0 | 1,543,989 | SEC↗ |
| AQXP AQUINOX PHARMACEUTICALS, I | D To issuer | 2014-03-12 | 2014-03-14 | 284,090 | — | $0 | 0 | SEC↗ |
| AQXP AQUINOX PHARMACEUTICALS, I | D To issuer | 2014-03-12 | 2014-03-14 | 40,147 | — | $0 | 0 | SEC↗ |
| AQXP AQUINOX PHARMACEUTICALS, I | A Award | 2014-03-12 | 2014-03-14 | 36,502 | — | $0 | 40,147 | SEC↗ |
| AQXP AQUINOX PHARMACEUTICALS, I | A Award deriv | 2014-03-06 | 2014-03-10 | 8,333 | — | $0 | 8,333 | SEC↗ |